MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effects
연구 개요
상세 설명
This study focuses on testing the effectiveness of MyPatientPal+, the combination of MyPatientPal smartphone app and a newly developed provider dashboard, on patient quality of life, adherence to medications, and severity of side effects on patients who are on cancer treatment. Participants will use the MyPatientPal+ smartphone daily to complete daily patient reported outcome questions (PROs) for 8 weeks. Providers will enter information as desired and not on a set schedule.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Lead Clinical Research Associate
- 전화번호: +1 313-576-9735
- 이메일: phalorej@karmanos.org
연구 장소
-
-
Michigan
-
Detroit, Michigan, 미국, 48201
- Karmanos Cancer Institute
-
연락하다:
- Lead Clinical Research Associate
- 전화번호: +1 313-576-9735
- 이메일: phalorej@karmanos.org
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Patients-
- 18-70 Years of age
- have a diagnosis of breast, any gastrointestinal, lung, prostate, head and neck, or bladder cancer
- about to initiate chemotherapy using one of the regimens listed in the protocol
- be able to speak, read, and write English
- willing and able to provide consent
- have access to a stable internet connection
Providers:
- being a practicing oncologist
- treating patients at Karmanos Cancer Institute (KCI) who are enrolled and consent to using the MyPatientPal+ smartphone app
- provide consent for the study
Exclusion Criteria:
Patients-
- cognitive or perceptual disturbances that prevent completing study measures Provider-
- None
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: MyPatientPal+ Smartphone Application
Participants report daily side effects and medications. Application includes a provider dashboard to track patients side effects and medications. |
The intervention will consist of patients using the MyPatientPal+ application to complete daily patient reported outcome questions (PROs) of: (a) patient quality of life, (b) medication use, and (c) severity of side effects, and their providers who will elect to receive a weekly summary of patient's daily PRO reports electronically (e.g., email) or through the dashboard. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Single-item daily Quality of Life (Patient)
기간: Daily for 8 weeks
|
Patients will report their daily quality of life daily using MyPatientPal smartphone app. The question: "How was your quality of life today?" has a 7-point scale ranging from 1=very poor to 7=excellent. |
Daily for 8 weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Adherence to medications (patient)
기간: Daily for 8 weeks
|
Patients will report any medications they are taking related to their treatment. Each report will consist of them answering a forced-choice question about whether each of their prescribed medications was taken (0=yes, 1=no). The investigators will compare the ratio of total days of adherence/total number of days per medication between the weekly and daily reporting phases. There will be no set number of medications that will be assessed given that the app will be set up to record only those medications the patient is prescribed, but on average, most patients will report on 3 medications. Examples may include Xeloda, Ibrance, Femara, Tamoxifen, Remeron, Reglan, or Compazine. |
Daily for 8 weeks
|
|
Severity of side effects (patient)
기간: Daily for 8 weeks
|
The severity of treatment-related symptoms will be examined as the primary outcome. Patients will report the severity of symptoms selected to match their current or expected side using the National Cancer Institute (NCI) CTCAE (Common Terminology Criteria for Adverse Events). Examples include diarrhea, constipation, vomiting, fever, and fatigue. Patients will be asked to mark the severity of each symptom using a 5-point rating scale (from 0=none to 4=very severe). |
Daily for 8 weeks
|
|
Patient quality of life
기간: Weekly for 8 weeks
|
Patients will report their quality of life using the FACT-G (Functional Assessment of Cancer Therapy), a widely accepted measure of general functioning and quality of life among cancer patients. The measure has a total score and also four subscales assessing social, functional, emotional, and physical domains. |
Weekly for 8 weeks
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Felicity Harper, Ph.D., Barbara Ann Karmanos Cancer Institute
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2025-091
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .